CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-05-07 | O DONNELL MICHAEL J Director | Option exercise · Common Stock | −42,897 | $4.10 | $176K | 365,557 |
| 2013-05-01 | ROBERTSON SANFORD Director | Option exercise | +42,897 | $4.10 | $176K | 319,727 |
| 2013-05-01 | ROBERTSON SANFORD Director | Option exercise · (1) Common Stock | −42,897 | $4.10 | $176K | 610,771 |
| 2013-05-01 | SCHOENHARD GRANT Chief Scientific Officer | Other acquisition | +650 | $1.92 | $1K | 67,181 |
Page 17 of 17 · 324 trades